Eris Lifesciences Ltd 2024 Annual Report with Sustainability Disclosures
Company: Eris Lifesciences Ltd
Sector: Manufacturing
Country: India
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 355
The report describes a transformative FY24, with consolidated Revenue from Operations increasing to INR 20,091.43 million and growth across the company’s pharmaceutical portfolio. It also documents the Executive Committee’s oversight of ESG initiatives. Environmental actions include a Zero Liquid Discharge treatment process, energy-efficiency measures, and monitoring of energy-intensive operations. The BRSR provides extensive standalone environmental, employee, governance, and product-responsibility disclosures, while stating that no assurance was obtained.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.